These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion. Corbucci GG; Perrino C; Donato G; Ricchi A; Lettieri B; Troncone G; Indolfi C; Chiariello M; Avvedimento EV J Am Coll Cardiol; 2004 Jun; 43(11):1992-9. PubMed ID: 15172403 [TBL] [Abstract][Full Text] [Related]
6. [Postischemic ("stunned") and chronic ischemic ("hibernating") cardiac muscle]. Takác M; Koval S; Takác V Vnitr Lek; 1995 Apr; 41(4):252-7. PubMed ID: 7762191 [TBL] [Abstract][Full Text] [Related]
7. [Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia]. Atar D Schweiz Med Wochenschr; 1997 Nov; 127(48):2008-13. PubMed ID: 9490468 [TBL] [Abstract][Full Text] [Related]
8. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Kloner RA; Jennings RB Circulation; 2001 Dec; 104(24):2981-9. PubMed ID: 11739316 [TBL] [Abstract][Full Text] [Related]
9. Ischaemic heart disease: clinical improvement with metabolic approach. Ferrari R Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104 [TBL] [Abstract][Full Text] [Related]
11. Whole body heat shock fails to protect mouse heart against ischemia/reperfusion injury: role of 72 kDa heat shock protein and antioxidant enzymes. Xi L; Chelliah J; Nayeem MA; Levasseur JE; Hess ML; Kukreja RC J Mol Cell Cardiol; 1998 Nov; 30(11):2213-27. PubMed ID: 9925359 [TBL] [Abstract][Full Text] [Related]
12. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium]. Sokolova RI; Zhdanov VS Arkh Patol; 2002; 64(1):50-4. PubMed ID: 11889704 [TBL] [Abstract][Full Text] [Related]
13. [-Myocardial protection by preconditioning. Experimental and clinical significance-]. Strasser R; Vogt A; Schaper W Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986 [TBL] [Abstract][Full Text] [Related]
15. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. Hale SL; Kloner RA J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471 [TBL] [Abstract][Full Text] [Related]
16. Metabolic disarrangement in ischemic heart disease and its therapeutic control. Ferrari R Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638 [TBL] [Abstract][Full Text] [Related]
17. Preconditioning of heart by repeated stunning. Adaptive modification of antioxidative defense system. Das DK; Prasad MR; Lu D; Jones RM Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):739-49. PubMed ID: 1472901 [TBL] [Abstract][Full Text] [Related]
18. Myocardial stunning: an experimental act with a large clinical audience. Heyndrickx GR Arch Mal Coeur Vaiss; 2003 Jun; 96(6):665-70. PubMed ID: 12868349 [TBL] [Abstract][Full Text] [Related]
19. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Kloner RA; Jennings RB Circulation; 2001 Dec; 104(25):3158-67. PubMed ID: 11748117 [TBL] [Abstract][Full Text] [Related]
20. [Metabolic issues of ischemia induced myocardial dysfunction]. Mamamtavrishvili ND; Sharashidze NS; Abashidze RI; Kvirkveliia AA Georgian Med News; 2011 Jun; (195):40-3. PubMed ID: 21778539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]